EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access

Long-Term Outcomes After Proton Therapy Versus Intensity Modulated Photon Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Post Hoc Analysis of a Prospective Randomized Trial

Tingshi Su, Ting Xu, Mei Chen, Xinru Chen, Quynh-Nhu Nguyen, Stephen G Chun, Steven H Lin, Joe Y Chang, John V Heymach, Anne Tsao, Anita Deswal, Efstratios Koutroumpakis und 15 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026

DOI: 10.1016/j.ijrobp.2026.05.012 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026. Verfasst von Tingshi Su und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Guang…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Chemoradiotherapy, Lung Neoplasms, Photons. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To report long-term toxicity and disease outcomes from a randomized trial comparing passive scattering proton therapy (PSPT) and intensity modulated photon radiation therapy (IMRT), both with concurrent chemotherapy, for non-small cell lung cancer. METHODS AND MATERIALS: One hundred forty-nine patients with locally advanced non-small cell lung cancer were randomly assigned to IMRT or PSPT; 147 completed the assigned treatment. Local failure, radiation pneumonitis (RP), major adverse cardiac events (MACEs), long-term esophageal toxicity, and survival were estimated and compared between IMRT and PSPT. Risk factors for each endpoint were analyzed using Cox proportional hazards regression or competing-risks regression. RESULTS: The median follow-up time was 28.5 months (29.7 months IMRT, 26.2 months PSPT); 7 patients were lost to follow-up. Grade ≥3 RP was experienced by 10 patients in the IMRT group (10.9%) and 6 in the PSPT group (10.5%; P = .98); 2 patients treated with IMRT and no patients treated with PSPT had grade 5 RP. Pre-existing pulmonary disease and mean lung dose were found to be associated with grade ≥3 RP. Esophageal toxicity rates did not differ between groups and consisted of 7 grade 3 strictures and 1 secondary cancer. Of the 10 definitely/possibly radiation-related MACEs, 1 was in PSPT, and 9 were in IMRT; doses to coronary arteries may have been associated with MACE. No differences were found in local failure or progression-free survival. Tumor volume and radiation dose influenced survival outcomes. CONCLUSIONS: When both IMRT and PSPT plans met dose-volume constraints for the lung, no differences were found in lung toxicity or local failure after IMRT versus PSPT, consistent with our original findings. PSPT led to fewer cases of radiation-related MACE, presumably from reduced radiation dose to the coronary arteries. Survival outcomes were comparable to those of Radiation Therapy Oncology Group 0617, a phase 3 trial that included only patients with stage IIB to IIIA disease and good performance status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungChemoradiotherapyLung NeoplasmsPhotonsProton TherapyRadiotherapy, Intensity-ModulatedAgedFemaleHumansMaleMiddle AgedEsophagusFollow-Up StudiesHeartProportional Hazards ModelsProspective StudiesRadiation PneumonitisTreatment Outcome

Autor:innen und Institutionen

  • Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
  • Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Departments of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Departments of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Departments of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Departments of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • National Institutes of Health
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Su, T., Xu, T., Chen, M., Chen, X., Nguyen, Q. N., Chun, S. G., Lin, S. H., Chang, J. Y., Heymach, J. V., Tsao, A., Deswal, A., Koutroumpakis, E., Qian, D., Bronk, J., Ning, M., Chen, A., O'Reilly, M., Gandhi, S., Fossella, F. V., …, & Liao, Z. (2026). Long-Term Outcomes After Proton Therapy Versus Intensity Modulated Photon Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Post Hoc Analysis of a Prospective Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2026.05.012

Vancouver

Su T, Xu T, Chen M, Chen X, Nguyen QN, Chun SG, et al. Long-Term Outcomes After Proton Therapy Versus Intensity Modulated Photon Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Post Hoc Analysis of a Prospective Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2026.05.012

BibTeX
@article{Su2026,
  author = {Su, Tingshi and Xu, Ting and Chen, Mei and Chen, Xinru and Nguyen, Quynh-Nhu and Chun, Stephen G and Lin, Steven H and Chang, Joe Y and Heymach, John V and Tsao, Anne and Deswal, Anita and Koutroumpakis, Efstratios and Qian, David and Bronk, Julianna and Ning, Matt and Chen, Aileen and O'Reilly, Michael and Gandhi, Saumil and Fossella, Frank V and Blumenschein, George R and Vaporciyan, Ara A and Swisher, Stephen G and Lu, Charles S and Mohan, Radhe and Zhang, Xiaodong and Lee, Jiun-Kae Jack and Liao, Zhongxing},
  title = {Long-Term Outcomes After Proton Therapy Versus Intensity Modulated Photon Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Post Hoc Analysis of a Prospective Randomized Trial},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  doi = {10.1016/j.ijrobp.2026.05.012}
}
Kostenlos starten →